This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Psoralen
- DrugBank Accession Number
- DB18665
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Psoralen (DB18665)
- Weight
- Average: 186.166
Monoisotopic: 186.031694053 - Chemical Formula
- C11H6O3
- Synonyms
- 6-hydroxy-5-benzofuranacrylic acid .delta.-lactone
- Ficusin
- External IDs
- NSC-404562
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Anthelmintics
- Anti-Infective Agents
- Antiparasitic Agents
- Benzopyrans
- Compounds used in a research, industrial, or household setting
- Coumarins
- Cross-Linking Reagents
- Dermatologicals
- Furocoumarins
- Heterocyclic Compounds, Fused-Ring
- Indicators and Reagents
- Laboratory Chemicals
- Photosensitizing Agents
- Pyrans
- Radiation-Sensitizing Agents
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- KTZ7ZCN2EX
- CAS number
- 66-97-7
- InChI Key
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N
- InChI
- InChI=1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H
- IUPAC Name
- 7H-furo[3,2-g]chromen-7-one
- SMILES
- O=C1OC2=CC3=C(C=CO3)C=C2C=C1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0034272
- KEGG Compound
- C09305
- ChemSpider
- 5964
- BindingDB
- 50331544
- 2103294
- ChEBI
- 27616
- ChEMBL
- CHEMBL164660
- ZINC
- ZINC000000120283
- Wikipedia
- Psoralen
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Terminated Treatment Aplastic Anemia / Leukemias / Lymphoma / Multiple Myeloma (MM) 1 1 Completed Treatment Leukemias / Lymphoma / Multiple Myeloma and Plasma Cell Neoplasm / Myelodysplastic Syndrome 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 1.94 Chemaxon pKa (Strongest Basic) -2.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 39.44 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 50.39 m3·mol-1 Chemaxon Polarizability 18.1 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 11, 2023 22:58 / Updated at October 12, 2023 21:51